A Neoadjuvant, Randomized, Open-Label Phase II Trial of Afatinib Versus Trastuzumab Versus Lapatinib in Patients With Locally Advanced HER2-Positive Breast Cancer
Titel:
A Neoadjuvant, Randomized, Open-Label Phase II Trial of Afatinib Versus Trastuzumab Versus Lapatinib in Patients With Locally Advanced HER2-Positive Breast Cancer
Auteur:
Rimawi, Mothaffar F. Aleixo, Sabina B. Rozas, Ashley Alarcon Nunes de Matos Neto, João Caleffi, Maira Figueira, Alicardo Cesar Souza, Sulene Cunha Reiriz, Andre B. Gutierrez, Carolina Arantes, Heloisa Uttenreuther-Fischer, Martina M. Solca, Flavio Osborne, C. Kent